Ceryvyn Therapeutics Limited
Important Dates
Ceryvyn Therapeutics Limited's next confirmed earnings release is scheduled for February 23, 2027.
| Earnings Date | 2/23/2027 |
Share Statistics
As of December 31, 2024, Ceryvyn Therapeutics Limited has 1.23B shares outstanding.
| Shares Outstanding | 1.23B |
Financial Position
As of December 31, 2024, Ceryvyn Therapeutics Limited maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.57 |
| Quick Ratio | 1.52 |
| Debt / Equity | -93.21 |
Stock Price Statistics
AUDThese figures are as of the close on October 22, 2026.
| 50-Day Moving Average | 0.01 |
Balance Sheet
AUDAs of December 31, 2024, Ceryvyn Therapeutics Limited holds 212.14M in cash and equivalents against 252.88M in total debt, resulting in a net debt position of 40.68M. Total book value stands at -271.30M, with working capital of 84.23M providing operational flexibility.
| Cash & Cash Equivalents | 212.14M |
| Total Debt | 252.88M |
| Net Debt | 40.68M |
| Equity (Book Value) | -271.30M |
| Book Value Per Share | -0.22 |
| Working Capital | 84.23M |
Cash Flow
AUDThese figures cover the twelve months ended December 31, 2024.
| Capital Expenditures | -20,906.08 |
Stock Splits
Ceryvyn Therapeutics Limited's most recent stock split took place on June 14, 2024 with a 35:38 split ratio.
| Last Split Date | 6/14/2024 |
| Split Ratio | 35:38 |